Management believes SOHM India’s manufacturing infrastructure is in place to grow sales of its private label generic pharmaceutical and nutraceutical product lines.
Shailesh Shah, vice president for corporate strategy at SOHM, said: “We expect continued growth in 2010 from our large distributor networks as they continue to implement a new growth strategy, introduced late last year, to expand sales of our private-label generic pharmaceutical and nutraceutical products.
“We also expect growth with our global distributors as our products gain a more prominent presence in the pharmaceutical markets in South East Asia and Africa.”